Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer. - Concepedia

Concepedia

Publication | Closed Access

Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer.

65

Citations

0

References

1996

Year

G.J. Creemers, C J Gerrits, Jan H.M. Schellens, André Planting, M E van der Burg, V M van Beurden, M de Boer-Dennert, Miranda Harteveld, Walter J. Loos, I Hudson,

Journal of Clinical Oncology

Abstract

Topotecan administered as a 21-day continuous infusion exerts minor activity as single-agent therapy in patients with metastatic colorectal cancer.